All News

A woman with stage 4 inflammatory breast cancer details her journey with the disease and why it is important for patients to ask questions about anything going on with their bodies.

Mezigdomide plus Velcade and dexamethasone or Kyprolis and dexamethasone showed promising response rates across multiple doses in patients with relapsed or refractory multiple myeloma, research showed.

Back 50 years or so ago, people didn’t discuss cancer freely. Today, things have changed.

As Connor McGregor honors a fan who dies from cancer and Steve Scalise reveals information about his blood cancer, this is what’s happening in the oncology space this week.

While much progress has been made in treating blood cancers like lymphoma, I know that there is still far more work to be done.

CURE looks back on some of the most important stories in the chronic lymphocytic leukemia space from 2023.

Tecentriq plus carboplatin and pemetrexed may improve efficacy in patients with NSCLC with untreated brain metastases, according to results of a phase 2 trial.

This is how I accepted that I am running out of time and options.

An expert discusses what patients can expect when being treated with the Hepzato kit, a direct-to-liver therapy for metastatic uveal melanoma.

Ashton’s story starts with her. Our beautiful, big-hearted, kind girl.

Patients with chronic lymphocytic leukemia treated with Imbruvica plus Venclexta demonstrated a healthy immune profile over time in addition to reduction in CLL disease burden.

When both a patient and their loved one acting as their caregiver are facing cancer, “there has to be proper care for both,” one expert tells CURE®.

The very first blog I ever wrote for CURE asked the question, “Why me?”

The recent FDA approval of Aphexda combined with filgrastim improved the collection of stem cells in patients with multiple myeloma.

The FDA approved Bosulif for children aged 1 and older with newly diagnosed or resistant/intolerant chronic myelogenous leukemia.

Treatment of Opdivo and Stivarga plus chemotherapy improves survival in patients with advanced esophageal adenocarcinoma and certain esophageal and stomach cancers.

Benmelstobart plus anlontinib with a chemotherapy combination improved survival outcomes for patients with extensive-stage small cell lung cancer.

In honor of National Childhood Cancer Awareness Month in September, here’s a look back at some of the top pediatric cancer developments from 2023.

Piqray led to elevated blood sugar in many patients with breast cancer, a recent research showed.

Trust me, I made the mistake of blaming every symptom on my cancer.

Lifestyle changes and remedies such as topical estrogen can be of assistance to cancer survivors dealing with hormone deficiencies, as one expert tells CURE.

Padcev plus Keytruda may improve survival outcomes for some patients with advanced urothelial cancer, according to preliminary data.

Most oncology clinics screen for psychosocial distress among patients with cancer, but the same can’t be said for their caregivers, recent research found.

“If prognosis is just weeks to months and pain is well-controlled, (I’m) not sure I really care about other illicit substance use,” said one member of a panel evaluating opioid management approaches among patients experiencing advanced cancer-related pain and using nonmedical stimulants.

October brings many mixed emotions to mind as a breast cancer survivor.

More than half of patients may experience PMPS, a type of chronic nerve pain, following mastectomy and breast surgery.

There are many immunotherapy-caused skin toxicities, though most can be easily managed.

During chemotherapy, strawberry-flavored Boost and baked potatoes were the only things I would eat — but this nourishment ended up representing much more.

The second phase of a study evaluating androgen receptor inhibitor masofaniten combined with antiandrogen Xtandi for the treatment of patients with metastatic castration-resistant prostate cancer has been launched.

The highs, lows and a courageous decision that changed everything.